Sfoglia per RIVISTA
LUNG CANCER (AMSTERDAM, NETHERLANDS)
Collezione AOU San Luigi di Orbassano
Items : 41
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Oct;196:107921. doi: 10.1016/j.lungcan.2024.107921. Epub 2024 Aug 6.
2024
AOU San Luigi di Orbassano
Waterhouse DM; Rothschild S; Dooms C; Mennecier B; Bozorgmehr F; Majem M; van den Heuvel MH; Linardou H; Chul Cho B; Roberts-Thomson R; Tanaka K; Blais N; Schvartsman G; Holmskov Hansen K; Chmielewska I; Forster MD; Giannopoulou C; Stollenwerk B; Obiozor CC; Wang Y; Novello S;
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21.
2024
AOU San Luigi di Orbassano
Bertolaccini L; Tralongo AC; Del Re M; Facchinetti F; Ferrara R; Franchina T; Graziano P; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Cinquini M; Passiglia F; Novello S;
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 May;191:107787. doi: 10.1016/j.lungcan.2024.107787. Epub 2024 Apr 5.
2024
AOU Alessandria
AOU San Luigi di Orbassano
Troncone G; Righi L; Genova C; Tiseo M; Pilotto S; Pasello G; Piovano P; Pagni F; Graziano P; Garbo E; Cortinovis D; Fraggetta F; Galetta D; Lucia Reale M; Pisapia P; Novello S; Pepe F; Passiglia F; Malapelle U;
Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15.
2023
AOU San Luigi di Orbassano
Reck M; Popat S; Grohé C; Corral J; Novello S; Gottfried M; Brueckl W; Radonjic D; Kaiser R; Heymach J;
Drive the oncologists into exercise promotion in lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 Feb;176:1-3. doi: 10.1016/j.lungcan.2022.12.009. Epub 2022 Dec 22.
2023
AOU San Luigi di Orbassano
Novello S; Pilotto S; Schena F; Milella M; Belluomini L; Avancini A;
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 May;167:98-106. doi: 10.1016/j.lungcan.2022.01.008. Epub 2022 Jan 22.
2022
AOU San Luigi di Orbassano
Lantuéjoul S; Fernandez-Cuesta L; Letouzé E; Demontrond P; Audigier-Valette C; Girard N; Giaj Levra M; Cadranel J; Mondet J; Novello S; Antoine M; Brevet M; Foll M; Mc Leer A; Moro-Sibilot D;
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Dingemans AC; von der Thüsen J; Remon J; Reguart N; O'Brien M; Reck M; Novello S; Mauer M; Lantuejoul S; Hendriks L; Greillier L; Girard N; Faivre-Finn C; Edwards J; De Ruysscher D; Brandão M; Bironzo P; Berghmans T; Giaj Levra M; Sperduti I; Menis J; Pilotto S; Avancini A; Milella M; Besse B;
Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:9-16. doi: 10.1016/j.lungcan.2021.05.017. Epub 2021 May 24.
2021
AOU San Luigi di Orbassano
Kruhl C; Bent-Ennakhil N; Pérol M; Hochmair M; Helland Å; Griesinger F; Garassino MC; Felip E; Cadranel J; Brustugun OT; Popat S; Novello S;
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:85-91. doi: 10.1016/j.lungcan.2021.05.009. Epub 2021 May 11.
2021
AOU San Luigi di Orbassano
Capelletto E; Bironzo P; Consito L; Bertaglia V; Reale ML; Tabbò F; Delcuratolo MD; Olmetto E; Leone G; Passiglia F; Novello S;
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Feb;152:127-134. doi: 10.1016/j.lungcan.2020.12.011. Epub 2020 Dec 17.
2021
AOU San Luigi di Orbassano
Novello S; Mukhametshina GZ; Schumacher M; Rizzato S; Ostoros G; Tsoi D; Gottfried M; Metro G; Migliorino MR; Passaro A; Hochmair M; Egorova I; Poltoratskiy A; Laktionov KK; de Marinis F; Dziadziuszko R; Tang W; Clementi L; Cseh A; Kowalski D;
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20.
2020
AOU San Luigi di Orbassano
Radonjic D; Gottfried M; Novello S; Reck M; Corral J; Grohé C; Popat S; Kaiser R;
Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:216-218. doi: 10.1016/j.lungcan.2019.11.005. Epub 2019 Nov 13.
2020
AOU San Luigi di Orbassano
Besse B; Dingemans AC; Levy A; Novello S; Hendriks LE; Berghmans T; Giaj Levra M; Giaj-Levra N;
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Perrone F; Novello S; Scagliotti GV; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Trevisi E; Leone G; Mariniello A; Di Stefano RF; Pignataro D; Ghisoni E; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML;
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Feb;140:71-79. doi: 10.1016/j.lungcan.2019.12.006. Epub 2019 Dec 16.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Torino 4
AOU Alessandria
AOU Novara
Novello S; Rossi A; Ferrari S; Zullo A; Carta A; Vattemi E; Pagano M; Gelibter A; Martelli O; Pino MS; Cecere F; Berardi R; Migliorino MR; Tonini G; Galetta D; Sergi C; Nonnis D; Verderame F; Del Conte A; Scotti V; Borra G; Piovano PL; Ceresoli GL; Finocchiaro G; Romano GD; Cortinovis D; Vitiello F; Tiseo M; Barbieri F; et alii...
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Oct;136:145-147. doi: 10.1016/j.lungcan.2019.08.007. Epub 2019 Aug 13.
2019
AOU San Luigi di Orbassano
Reck M; Berghmans T; Hasan B; Novello S; Dingemans AC; Besse B; Falk S; Le Péchoux C; Hendriks LEL; Levy A; Faivre-Finn C;
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.
2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
Novello S; Migliaretti G; Pacchiana MV; Stura I; Critelli R; Metro G; Morelli AM; Manzo A; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Pisconti S; Ceresoli GL; Del Conte A; Gregorc V; Scotti V; Galetta D; Romano G; Grossi F; Delmonte A; Costanzo FD; Tiseo M; Chiari R; Morabito A; Capelletto E; Migliorino MR;
Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Ordine Mauriziano
Novello S; Bordi P; Catino A; Pisconti S; Cortinovis D; Franchina T; Migliorino MR; Delmonte A; Buffoni L; Ceribelli A; Scotti V; Riccardi F; Gregorc V; Di Maio M; Rossi G; Bria E; Rossi A; Graziano P; Tiseo M; Galetta D; Gobbini E; Maiello E; Arizio F;
Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:124-130. doi: 10.1016/j.lungcan.2017.07.013. Epub 2017 Jul 20.
2017
AOU San Luigi di Orbassano
Gagliasso M; Migliaretti G; Ardissone F;
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 May;107:84-90. doi: 10.1016/j.lungcan.2016.05.021. Epub 2016 May 31.
2017
AOU San Luigi di Orbassano
Vavalà T; Monica V; Lo Iacono M; Mele T; Busso S; Righi L; Papotti M; Scagliotti GV; Novello S;
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Feb;104:45-51. doi: 10.1016/j.lungcan.2016.12.007. Epub 2016 Dec 12.
2017
AOU San Luigi di Orbassano
Paz-Ares LG; Zimmermann A; Ciuleanu T; Bunn PA; Antonio BS; Denne J; Iturria N; John W; Scagliotti GV;
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 Oct;100:20-23. doi: 10.1016/j.lungcan.2016.06.023. Epub 2016 Jun 27.
2016
AOU San Luigi di Orbassano
Scagliotti G; Nishio M; Satouchi M; Valmadre G; Niho S; Galetta D; Cortinovis D; Benedetti F; Yoshihara E; Makris L; Inoue A; Kubota K;
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano
AOU Alessandria
Rossi A; Spitaleri G; Bria E; Cecere F; Rijavec E; Rizzo E; Barbieri F; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Novello S; Martelli O; Di Maio M; Morabito A; Vavalà T; Follador A; Tiseo M; Galetta D;
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Sep;89(3):350-6. doi: 10.1016/j.lungcan.2015.06.019. Epub 2015 Jun 26.
2015
AOU San Luigi di Orbassano
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S;
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19.
2015
AOU San Luigi di Orbassano
Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 May;88(2):160-6. doi: 10.1016/j.lungcan.2015.02.014. Epub 2015 Feb 23.
2015
AOU San Luigi di Orbassano
Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S;
Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Mar;87(3):226-31. doi: 10.1016/j.lungcan.2015.01.008. Epub 2015 Jan 17.
2015
AOU San Luigi di Orbassano
Pelosi G; Barbareschi M; Cavazza A; Graziano P; Rossi G; Papotti M;
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.
2015
AOU San Luigi di Orbassano
Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A;
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2014 Sep;85(3):408-14. doi: 10.1016/j.lungcan.2014.07.005. Epub 2014 Jul 16.
2014
AOU San Luigi di Orbassano
Scagliotti GV; Gridelli C; de Marinis F; Thomas M; Dediu M; Pujol JL; Manegold C; San Antonio B; Peterson PM; John W; Chouaki N; Visseren-Grul C; Paz-Ares LG;
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2010 Jun;68(3):420-6. doi: 10.1016/j.lungcan.2009.07.011. Epub 2009 Aug 18.
2010
AOU San Luigi di Orbassano
Scagliotti GV; Germonpré P; Bosquée L; Vansteenkiste J; Gervais R; Planchard D; Reck M; De Marinis F; Lee JS; Park K; Biesma B; Gans S; Ramlau R; Szczesna A; Makhson A; Manikhas G; Morgan B; Zhu Y; Chan KC; von Pawel J;
Multimodality approach to early-stage non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2007 Aug;57 Suppl 2:S6-11. doi: 10.1016/S0169-5002(07)70421-X.
2007
AOU San Luigi di Orbassano
Scagliotti G;
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2005 Oct;50(1):91-6. doi: 10.1016/j.lungcan.2005.05.012.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G;
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2005 Feb;47(2):269-75. doi: 10.1016/j.lungcan.2004.06.019.
2005
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Dongiovanni D; Fissore C; Berruti A; Buffoni L; Addeo A; Barone C; Polimeni MA; Ottaviani D; Bertetto O; Dongiovanni V;
Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2004 Dec;46 Suppl 2:S13-21. doi: 10.1016/s0169-5002(04)80037-0.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Douillard JY;
Adjuvant chemotherapy after complete resection for early stage NSCLC. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2003 Dec;42 Suppl 1:S47-51. doi: 10.1016/s0169-5002(03)00304-0.
2003
AOU San Luigi di Orbassano
Scagliotti G; Novello S;
Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Nov;38 Suppl 2:S13-9. doi: 10.1016/s0169-5002(02)00352-5.
2002
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Dec;38 Suppl 3:S23-9. doi: 10.1016/s0169-5002(02)00262-3.
2002
AOU San Luigi di Orbassano
Scagliotti G;
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0.
2001
AOU San Luigi di Orbassano
Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti GV;
Role of erythropoietin in the treatment of lung cancer associated anaemia. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Dec;34 Suppl 4:S91-4. doi: 10.1016/s0169-5002(01)00398-1.
2001
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1999 Jul;25(1):39-46. doi: 10.1016/s0169-5002(99)00048-3.
1999
AOU San Luigi di Orbassano
Scagliotti GV; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M;
Biological prognostic factors in non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1995 Apr;12 Suppl 1:S13-25. doi: 10.1016/0169-5002(95)00417-y.
1995
AOU San Luigi di Orbassano
Scagliotti GV; Masiero P; Pozzi E;